One confirmed and one suspected case of pharyngeal gonorrhoea treatment failure following 500mg ceftriaxone in Sydney, Australia

Sexual Health

Volumn 10, Issue 5, 2013, Pages 460-462

  Read, Phillip J ^a,b   Limnios, E Athena ^c   McNulty, Anna ^a,d   Whiley, David ^e   Lahra, Monica M ^c  

^a Sydney Sexual Health Centre   (Australia)

^b UNIVERSITY OF NEW SOUTH WALES   (Australia)

^c PRINCE OF WALES HOSPITAL   (Australia)

^d UNIVERSITY OF NEW SOUTH WALES   (Australia)

^e UNIVERSITY OF QUEENSLAND   (Australia)

Author keywords

cephalosporin; drug resistance; multiantigen sequence type; multilocus sequence type

Indexed keywords

AZITHROMYCIN; CEFTRIAXONE; COLISTIN; NYSTATIN; TRIMETHOPRIM; VANCOMYCIN;

ANTIBIOTIC SENSITIVITY; ARTICLE; AUSTRALIA; DNA SEQUENCE; GONORRHEA; GRAM STAINING; MULTI ANTIGEN SEQUENCE TYPING; MULTILOCUS SEQUENCE TYPING; NEISSERIA GONORRHOEAE; PHARYNGEAL GONORRHEA; PHARYNGITIS; POLYMERASE CHAIN REACTION; REINFECTION; SINGLE DRUG DOSE; TREATMENT FAILURE; URETHRAL DISCHARGE;

ADULT; ANTI-BACTERIAL AGENTS; AUSTRALIA; CEFTRIAXONE; GONORRHEA; HOMOSEXUALITY, MALE; HUMANS; MALE; PHARYNGEAL DISEASES; TREATMENT FAILURE; YOUNG ADULT;

EID: 84886926874     PISSN: 14485028     EISSN: 14498987     Source Type: Journal    
DOI: 10.1071/SH13077     Document Type: Article

References (13)

1. Whiley D, Goire N, Lahra M, Donovan B, Limnios A, Nissen M, et al. The ticking time bomb: escalating antibiotic resistance in Neisseria gonorrhoeae is a public health disaster in waiting. J Antimicrob Chemother 2012; 67(9): 2059-61. doi:10.1093/jac/dks188
2. Unemo M, Golparian D, Stary A, Eigentler A. First Neisseria gonorrhoeae strain with resistance to cefixime causing gonorrhoea treatment failure in Austria, 2011. Euro Surveill 2011; 16(43): 19998
3. Centres for Disease Control and Prevention. Update to CDC's sexually transmitted diseases treatment guidelines, 2010: oral cephalosporins no longer a recommended treatment for gonococcal infections. MMWR Morb Mortal Wkly Rep 2012; 61(31): 590-4.
4. Ohnishi M, Golparian D, Shimuta K, Saika T, Hoshina S, Iwasaku K, et al. Is Neisseria gonorrhoeae initiating a future era of untreatable gonorrhea? Detailed characterization of the first strain with high-level resistance to ceftriaxone. Antimicrob Agents Chemother 2011; 55: 3538-45. doi:10.1128/AAC. 00325-11
5. Unemo M, Golparian D, Nicholas R, Ohnishi M, Gallay A, Sednaoui P. High-level cefixime-and ceftriaxone-resistant Neisseria gonorrhoeae in Europe (France): novel penA mosaic allele in a successful international clone causes treatment failure. Antimicrob Agents Chemother 2012; 56: 1273-80. doi:10.1128/AAC.05760-11
6. Tapsall J, and members of the National Neisseria Network of Australia. Animicrobial testing and applications in the pathogenic Neisseria. In Merlino J, editor. Antimicrobial susceptibility testing: methods and practices with an Australian perspective. Sydney: Australian Society for Microbiology; 2004. pp. 175-88.
7. Bennett JS, Jolley KA, Sparling PF, Saunders NJ, Hart CA, Feavers IM, et al. Species status of Neisseria gonorrhoeae: evolutionary and epidemiological inferences from multilocus sequence typing. BMC Biol 2007; 5: 35. doi:10.1186/1741-7007-5-35
8. Martin IM, Ison CA, Aanensen DM, Fenton KA, Spratt BG. Rapid sequence-based identification of gonococcal transmission clusters in a large metropolitan area. J Infect Dis 2004; 189(8): 1497-505. doi:10.1086/383047
9. Whiley DM, Limnios EA, Ray S, Sloots TP, Tapsall JW. Diversity of penA alterations and subtypes in Neisseria gonorrhoeae strains from Sydney, Australia, that are less susceptible to ceftriaxone. Antimicrob Agents Chemother 2007; 51(9): 3111-6. doi:10.1128/AAC.00306-07
10. Chen M, Stevens K, Tideman R, Zaia A, Tomita T, Fairley C, et al. Failure of 500 mg of ceftriaxone to eradicate pharyngeal gonorrhoea. Aust J Antimicrob Chemother 2013; 68(6): 1445-7. doi:10.1093/jac/dkt017
11. Tapsall J, Read P, Carmody C, Bourne C, Ray S, Limnios A, et al. Two cases of failed ceftriaxone treatment in pharyngeal gonorrhoea verified by molecular microbiological methods. J Med Microbiol 2009; 58: 683-7. doi:10.1099/jmm.0.007641-0
12. World Health Organization (WHO), Department of Reproductive Health and Research. Global action plan to control the spread and impact of antimicrobial resistance in Neisseria gonorrhoeae. Geneva: WHO; 2012. Available online at: http://whqlibdoc.who.int/publications/2012/9789241503501-eng.pdf [verified January 2013].
13. Bignell C, Fitzgerald M. UK national guideline for the management of gonorrhoea in adults, 2011. Int J STD AIDS 2011; 22: 541-7. doi:10.1258/ijsa. 2011.011267